Funding · Company
Moonwalk Biosciences, Inc.
South San Francisco, CABiotech & Pharma
Moonwalk Biosciences, Inc. of South San Francisco, CA has disclosed $110M across 2 Form D offerings filed with the SEC between Jan 2, 2024 and Sep 14, 2026.
$110M
Total disclosed
2
Form D offerings
2022
Incorporated
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$60M
Form D · Sep 14, 2026 ↗
Q3 2026
· target $70M
$50M
Form D · Jan 2, 2024 ↗
Q1 2024
· target $57M
Filing details
HeadquartersSouth San Francisco, CAIndustryBiotech & Pharma (Biotechnology)Incorporated2022SEC CIK0002004362Offerings on file2
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. Spot an error? Full methodology →